A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma
| dc.contributor.author | Awad, Mary | |
| dc.contributor.author | Holzwanger, Erik | |
| dc.contributor.author | Jubbal, Sandeep | |
| dc.date | 2022-08-11T08:09:56.000 | |
| dc.date.accessioned | 2022-08-23T16:49:15Z | |
| dc.date.available | 2022-08-23T16:49:15Z | |
| dc.date.issued | 2020-04-07 | |
| dc.date.submitted | 2020-05-08 | |
| dc.identifier.citation | <p>Awad M, Holzwanger E, Jubbal S. A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma. Case Rep Dermatol Med. 2020 Apr 7;2020:8310602. doi: 10.1155/2020/8310602. PMID: 32318298; PMCID: PMC7166262. <a href="https://doi.org/10.1155/2020/8310602">Link to article on publisher's site</a></p> | |
| dc.identifier.issn | 2090-6463 (Linking) | |
| dc.identifier.doi | 10.1155/2020/8310602 | |
| dc.identifier.pmid | 32318298 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/41425 | |
| dc.description.abstract | Cutaneous B-cell lymphomas (CBCL) are rare heterogeneous neoplastic diseases composing about 22.5% of all cutaneous lymphomas. These diseases can be divided into primary and secondary cutaneous variants with primary cutaneous B-cell lymphoma (PCBCL) divided into three distinct entities including primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT). Secondary cutaneous diffuse large B-cell lymphoma (CDLBCL) and PCDLBCL, LT are more aggressive neoplasms compared to the aforementioned CBCL with survival rates of 37% and 50% after 5 years, respectively. CDLBCL can present as cutaneous or subcutaneous nodules, papular lesions, or indurated plaques. Here, we present a case of CDLBCL of an 88-year-old female that was mistaken for lower extremity cellulitis with phlegmon. Our patient failed two courses of antibiotic therapy as an outpatient and received a third as an inpatient before a cutaneous biopsy clinched the diagnosis. | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32318298&dopt=Abstract">Link to Article in PubMed</a></p> | |
| dc.rights | Copyright © 2020 Mary Awad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Cutaneous Diffuse Large B-Cell Lymphoma | |
| dc.subject | cutaneous lymphomas | |
| dc.subject | Dermatology | |
| dc.subject | Hematology | |
| dc.subject | Hemic and Lymphatic Diseases | |
| dc.subject | Neoplasms | |
| dc.subject | Oncology | |
| dc.subject | Skin and Connective Tissue Diseases | |
| dc.title | A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Case reports in dermatological medicine | |
| dc.source.volume | 2020 | |
| dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=5225&context=oapubs&unstamped=1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/4206 | |
| dc.identifier.contextkey | 17677182 | |
| refterms.dateFOA | 2022-08-23T16:49:15Z | |
| html.description.abstract | <p>Cutaneous B-cell lymphomas (CBCL) are rare heterogeneous neoplastic diseases composing about 22.5% of all cutaneous lymphomas. These diseases can be divided into primary and secondary cutaneous variants with primary cutaneous B-cell lymphoma (PCBCL) divided into three distinct entities including primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT). Secondary cutaneous diffuse large B-cell lymphoma (CDLBCL) and PCDLBCL, LT are more aggressive neoplasms compared to the aforementioned CBCL with survival rates of 37% and 50% after 5 years, respectively. CDLBCL can present as cutaneous or subcutaneous nodules, papular lesions, or indurated plaques. Here, we present a case of CDLBCL of an 88-year-old female that was mistaken for lower extremity cellulitis with phlegmon. Our patient failed two courses of antibiotic therapy as an outpatient and received a third as an inpatient before a cutaneous biopsy clinched the diagnosis.</p> | |
| dc.identifier.submissionpath | oapubs/4206 | |
| dc.contributor.department | Department of Medicine | |
| dc.contributor.department | School of Medicine | |
| dc.source.pages | 8310602 |

